Dr. Eli Robert Groppo, MD

Dr. Groppo practices at Creekside Surgery Suite in Folsom, California.

Dr. Groppo's NPI, 1245402338, was assigned on March 28, 2008. Dr. Groppo graduated from George Washington University School of Medicine and Health Sciences in 2006. Dr. Groppo's California license number on file is A102807.

Dr. Groppo's primary practice is Creekside Surgery Suite, at 1561 Creekside Dr, Folsom, CA 95630 in Sacramento County. The practice phone is (916) 984-1600.

Dr. Groppo's primary practice is Creekside Surgery Suite in Folsom, California. Dr. Groppo is also affiliated with Mercy Hospital of Folsom. The medical group on file is Sacramento Ear, Nose & Throat. Dmand AI also links Dr. Groppo to 4 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Groppo practices, 7 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Groppo's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Groppo is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dr. Groppo has a license on file in California.

Dmand AI lists chronic ear infection, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, endoscopic sinus surgery, hearing loss and impairment, larynx and vocal cord disease and swimmer's ear among the conditions Dr. Groppo treats.

CMS data shows 1,767 Medicare services from Dr. Groppo across 20 procedure codes in 2024, for 521 Medicare patients. Medicare paid $130,325 for them. Every service was in an office.

CMS counts 521 Medicare patients who saw Dr. Groppo in 2024. The largest group is 65 to 74, with 254 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.12, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Groppo's median patient age at 61, with 55% women.

In 2024, Dr. Groppo wrote 615 Medicare Part D claims for 235 patients. 96% of them were for generic drugs. CMS names the drug for 492 of them, across 15 drugs with 11 or more claims each, at $29,051 in total drug cost. In 2023, CMS named 498 claims across 18 drugs.

Dr. Groppo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Groppo as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Dr. Groppo, published from 2012 to 2015. 2015 was the busiest year, with 2. The most frequent topics are Magnetic Resonance Imaging. Dr. Groppo's most frequent co-authors are David W. Eisele, MD, Robert Scott Meyer, MD and Maneesh Bawa, MD.

Dmand AI links Dr. Groppo to 1 clinical trial. Conditions studied include Gingival Neoplasms and Palatal Neoplasms.

CMS Open Payments shows 85 general payments to Dr. Groppo from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 53% of the total. Optinose US, Inc. paid the most, $3,794.

Dmand AI lists 2 awards for Dr. Groppo, most recently CMS Stage 1 EHR in 2013.

Dr. Groppo graduated from George Washington University School of Medicine and Health Sciences in 2006. Dr. Groppo is a member of NHS.

Dr. Groppo is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.